title: Tumor necrosis factor-alpha is persistently expressed in cardiac allografts in the absence of histological or clinical evidence of rejection.
authors.affiliation: Multi-Organ Transplant Center, Methodist Hospital, Houston, Texas, USA.
authors.forename: G
authors.initials: G
authors.lastname: Torre-Amione
authors.forename: W
authors.initials: W
authors.lastname: MacLellan
authors.forename: S
authors.initials: S
authors.lastname: Kapadia
authors.forename: D
authors.initials: D
authors.lastname: Weilbaecher
authors.forename: J
authors.initials: J
authors.lastname: Farmer
authors.forename: J
authors.initials: J
authors.lastname: Young
authors.forename: D
authors.initials: D
authors.lastname: Mann
mesh_terms: D001706:Biopsy; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000276:immunology / Q000473:pathology; D006085:Graft Survival / Q000276:immunology*; D016027:Heart Transplantation / Q000276:immunology* / Q000473:pathology; D006801:Humans; D015166:Monitoring, Immunologic; D009206:Myocardium / Q000276:immunology*; D013997:Time Factors; D014184:Transplantation, Homologous; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis*
chemical_list: D014409:Tumor Necrosis Factor-alpha